Maxwell Biosciences
Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. The company's platform effectively destroys viruses, ba...
Valuation
$50.9M
Market implied
Share Price
N/A
Total Raised
$35.5M
Last Round
N/A
Investors
+30 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details
Sector
Healthcare
Headquarters
Austin, TX, United States
Founded
2016
Employees
23
Website
maxwellbiosciences.com